Pro Medicus Limited - CEO Interview Highlights

Pro Medicus Limited (ASX: PME) delivered its strongest year on record, securing AU$520 million in new contracts, including its largest ever with Trinity Health, alongside significant upgrades and renewals worth AU$169 million. Over 98% of new contract revenue is yet to be realised, with forward contracted revenue for the next five years rising to AU$948 million. The company’s fully cloud-based Visage 7 platform remains a key differentiator, enabling faster, more secure, and scalable implementations compared to hybrid competitor models.

Expansion into cardiology and other “ologies,” including upcoming pathology solutions, is expected to boost contract values and market reach. Pro Medicus now holds 10% of the North American market, driven by rapid deployment, high client retention, and strategic upgrades. Margins remain strong at 74% EBIT, with potential for further growth from new contracts. AI initiatives, including collaborations with UCSF and NYU Langone, are set to enhance capabilities and future opportunities.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com